CClinicalTrials.gg
CompletedNCT05161273Updated Aug 26, 2024

Risk Factors for Lower Extremity Overuse Injuries in Jump-landing Athletes

An observational study in Landing Biomechanics and Fatigue, sponsored by University Ghent. Completed at 1 site in Belgium. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-26.

Sponsored by University Ghent · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 65 Years
Sex
Male
01

Study summary

In this prospective study, male jump-landing athletes (volleyball and basketball) will be screened pre-season and followed for one consecutive season. Pre-season screening consists of 3D biomechanical analysis of standardized (such as drop vertical jump) and sports-specific jumps (such as stop-jump) before and after a high-intensity, intermittent exercise protocol and clinical field tests (such as force measurements).

02

Conditions studied

  • Landing Biomechanics
  • Fatigue
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 150 is above the median of 100 across 367 observational studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy jump-landing athletes

Inclusion criteria

  • volleyball and basketball players
  • elite and non-elite
  • male
  • healthy

Exclusion criteria

Exclusion Criteria:

  • symptoms or complaints of lower extremity acute of overuse injuries in the past 3 months
  • history or surgery of the lower extremities
  • history of fractures of the lower extremities
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Target follow-up
1 Year
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Jump-landing biomechanics

    Full-body (trunk, pelvis, hip, knee, ankle) jump-landing biomechanics (3D joint angles and moments) during drop vertical jumps, block jumps and spike jumps

    Time frame: 1 year

  2. Jump-landing biomechanics after fatigue

    Full-body (trunk, pelvis, hip, knee, ankle) jump-landing biomechanics (3D joint angles and moments) during spike jumps during and after a fatigue protocol

    Time frame: 1 year

Secondary outcomes

  1. Clinical tests - force

    Force measurements of the quadriceps, hamstrings and gluteal muscles by means of hand-held dynamometry

    Time frame: 1 year

  2. Clinical tests - mobility

    Flexibility of the quadriceps and hamstrings muscles, and ankle dorsiflexion angle during dynamic weight-bearing lunge

    Time frame: 1 year

  3. Clinical tests - foot posture

    Navicular height and position of the calcaneal bone

    Time frame: 1 year

  4. Clinical tests - force endurance

    Prone bridge until fatigue

    Time frame: 1 year

  5. Clinical tests - endurance

    Intermittent yo-yo test (level 1)

    Time frame: 1 year

07

Study locations

1 site
  • Vakgroep Revalidatiewetenschappen
    Gent, Oost-Vlaanderen 9000, Belgium
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05161273
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Dec 17, 2021
Start date
Jun 1, 2021
Primary completion
Aug 1, 2022
Completion
Aug 20, 2024
Last update
Aug 26, 2024

Study contacts

Roosen
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion